X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (190) 190
Publication (26) 26
Book / eBook (5) 5
Book Review (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (114) 114
female (83) 83
male (82) 82
middle aged (71) 71
adult (68) 68
index medicus (64) 64
oncology (61) 61
aged (54) 54
clinical neurology (33) 33
treatment outcome (27) 27
aged, 80 and over (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
chemotherapy (24) 24
magnetic resonance imaging (22) 22
neoplasm staging (20) 20
neurology (20) 20
risk factors (20) 20
neurosciences (19) 19
adolescent (16) 16
camptothecin - analogs & derivatives (16) 16
stroke (16) 16
therapy (16) 16
adenocarcinoma (15) 15
cancer (15) 15
adenocarcinoma - drug therapy (14) 14
irinotecan (14) 14
mri (13) 13
survival analysis (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
disease progression (12) 12
disease-free survival (12) 12
esophageal cancer (12) 12
neoplasm metastasis (12) 12
brain - pathology (11) 11
drug administration schedule (11) 11
fluorouracil (11) 11
medical and health sciences (11) 11
medicin och hälsovetenskap (11) 11
surgery (11) 11
trial (11) 11
tumors (11) 11
young adult (11) 11
antineoplastic agents - therapeutic use (10) 10
article (10) 10
brain (10) 10
camptothecin - administration & dosage (10) 10
colorectal neoplasms - drug therapy (10) 10
growth-factor receptor (10) 10
oxaliplatin (10) 10
peripheral vascular disease (10) 10
prospective studies (10) 10
research (10) 10
adults (9) 9
care and treatment (9) 9
cell lung-cancer (9) 9
cetuximab (9) 9
cisplatin - administration & dosage (9) 9
cohort studies (9) 9
deoxycytidine - analogs & derivatives (9) 9
esophageal neoplasms - drug therapy (9) 9
medicine & public health (9) 9
multiple sclerosis (9) 9
survival rate (9) 9
capecitabine (8) 8
cisplatin (8) 8
clinical medicine (8) 8
fluorouracil - administration & dosage (8) 8
metaanalysis (8) 8
metastasis (8) 8
multicenter (8) 8
neurologi (8) 8
pancreatic neoplasms - drug therapy (8) 8
adenocarcinoma - pathology (7) 7
antibodies, monoclonal, humanized (7) 7
bevacizumab (7) 7
carcinoma (7) 7
colorectal neoplasms - pathology (7) 7
combination (7) 7
combined modality therapy (7) 7
diagnosis (7) 7
disease (7) 7
doxorubicin (7) 7
drug therapy (7) 7
esophageal neoplasms - pathology (7) 7
further section (7) 7
klinisk medicin (7) 7
medical research (7) 7
psychiatry (7) 7
quinazolines - administration & dosage (7) 7
research article (7) 7
stroke - epidemiology (7) 7
studies (7) 7
5-fluorouracil (6) 6
abnormalities (6) 6
adenocarcinoma - mortality (6) 6
administration, oral (6) 6
age factors (6) 6
antibodies, monoclonal - therapeutic use (6) 6
biomarkers (6) 6
clinical trials (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
Gerstein Science - Stacks (2) 2
OISE - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 01/2009, Volume 15, Issue 1, pp. 338 - 345
Purpose: Recent studies suggest that temozolomide has activity in neuroendocrine tumors. Low levels of the DNA repair enzyme, O-6-methylguanine DNA... 
MALIGNANT GLIOMA | PROMOTER HYPERMETHYLATION | O-METHYLGUANINE-DNA METHYLTRANSFERASE | PHASE-II TRIAL | SOUTHWEST-ONCOLOGY-GROUP | ISLET-CELL-CARCINOMA | ONCOLOGY | MGMT | O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | METHYLATION STATUS | DACARBAZINE
Journal Article
SEMINARS IN ONCOLOGY, ISSN 0093-7754, 12/2014, Volume 41, Issue 6, pp. S2 - S2
Gastric cancer is the second leading cause of cancer mortality and the fourth most common malignancy worldwide. An estimated 21,600 new cases of gastric cancer... 
ONCOLOGY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. TPS4139 - TPS4139
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. TPS4140 - TPS4140
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2016, Volume 16, Issue 1, p. 468
Background: Patients with locally advanced esophageal cancer who are treated with trimodality therapy have a high recurrence rate. Preclinical evidence... 
Neoadjuvant therapy | Cyclooxygenase 2 inhibition | Chemoradiation | Esophageal cancer | SURVIVAL | PLUS CISPLATIN | METAANALYSIS | COX-2 | ADENOCARCINOMA | CHEMORADIOTHERAPY | TRIAL | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | CYCLOOXYGENASE-2 EXPRESSION | COLORECTAL ADENOMAS | Celecoxib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nausea - chemically induced | Chemotherapy-Induced Febrile Neutropenia - etiology | Humans | Middle Aged | Male | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Cyclooxygenase 2 Inhibitors - adverse effects | Cyclooxygenase 2 Inhibitors - therapeutic use | Esophageal Neoplasms - mortality | Adult | Camptothecin - administration & dosage | Female | Esophageal Neoplasms - therapy | Camptothecin - analogs & derivatives | Celecoxib - adverse effects | Camptothecin - adverse effects | Chemoradiotherapy - methods | Camptothecin - therapeutic use | Drug Administration Schedule | Administration, Oral | Cyclooxygenase 2 Inhibitors - administration & dosage | Esophagogastric Junction - pathology | Celecoxib - therapeutic use | Disease-Free Survival | Deglutition Disorders - chemically induced | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Cisplatin - adverse effects | Anorexia - chemically induced | Aged | Neoplasm Staging | Dosage and administration | Celecoxib | Drug therapy | Radiotherapy | Methods
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 11/2011, Volume 9, Issue 11, pp. 1238 - 1289
Journal Article
by Fuchs, Charles S and Shitara, Kohei and Di Bartolomeo, Maria and Lonardi, Sara and Al-Batran, Salah-Eddin and Van Cutsem, Eric and Ilson, David H and Alsina, Maria and Chau, Ian and Lacy, Jill and Ducreux, Michel and Mendez, Guillermo Ariel and Alavez, Alejandro Molina and Takahari, Daisuke and Mansoor, Wasat and Enzinger, Peter C and Gorbounova, Vera and Wainberg, Zev A and Hegewisch-Becker, Susanna and Ferry, David and Lin, Ji and Carlesi, Roberto and Das, Mayukh and Shah, Manish A and Luft, Alexander V and Karaseva, Nina A and Kowalyszyn, Rubén Dario and Hernandez, Carlos Alberto and Csoszi, Tibor and De Vita, Ferdinando and Pfeiffer, Per and Sugimoto, Naotoshi and Kocsis, Judit and Csilla, Andràs and Bodoky, Gyorgy and Garnica Jaliffe, Georgina and Protsenko, Svetlana and Madi, Ayman and Wojcik, Elzbieta and Brenner, Baruch and Folprecht, Gunnar and Sarosiek, Tomasz and Peltola, Katriina Johanna and Bono, Peter and Ayala, Hubert and Aprile, Giuseppe and Gerardo, Cardellino Giovanni and Huitzil Melendez, Fidel David and Falcone, Alfredo and Di Costanzo, Francesco and Tehfe, Moustapha and Mineur, Laurent and García Alfonso, Pilar and Obermannova, Radka and Senellart, Hélène and Petty, Russell and Samuel, Leslie and Acs, Peter Istvan and Hussein, Maen Abdelkarim and Nechaeva, Marina N and Erdkamp, F.L.G and Won, Elizabeth and Bendell, Johanna Chock and Gallego Plazas, Javier and Lorenzen, Sylvie and Melichar, Bohuslav and Escudero, Miguel Angel and Pezet, Denis and Phelip, Jean-Marc and Kaen, Diego Lucas and Reeves, James A. Jr and Longo Muñoz, Federico and Madhusudan, Srinivasan and Barone, Carlo and Fein, Luis Enrique and Gomez Villanueva, Angel and Hebbar, Mohamed and Prausova, Jana and Visa Turmo, Laura and Vidal Barrull, Joana and Yilmaz, Mette Karen Nytoft and Beny, Alex and Van Laarhoven, H.M.W and DiCarlo, Brian Anthony and Esaki, Taito and Fujitani, Kazumasa and Geboes, Karen and Geva, Ravit and Kadowaki, Shigenori and Leong, Stephen and Machida, Nozomu and Raj, Moses Sundar and Ramirez Godinez, Francisco Javier and Ruzsa, Agnes and Ford, Hugo and Lawler, William E and Maisey, Nicolas Robert and Petera, Jiri and Shacham-Shmueli, Einat and Sinapi, Isabelle and ... and RAINFALL Study Grp and RAINFALL Study Group
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 420 - 435
VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to... 
EXPOSURE-RESPONSE | MULTICENTER | GASTROESOPHAGEAL JUNCTION | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | COMBINATION | CANCER | EXPRESSION | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma | Antimitotic agents | Care and treatment | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Rain and rainfall
Journal Article
Journal Article